[Anesthetic management of XXXX with @entity5030 accreta for cesarean section: a 7-year single-center experience].

@entity1 @entity548 @entity190 @entity5030 @entity432
BACKGROUND: Anesthetic management for cesarean section of @entity1 with @entity5030 accreta is challenging. The aim of this retrospective study was to review past @entity5030 accreta cases in our hospital to propose a better strategy for anesthetic management for this difficult condition. METHODS: Cases of @entity5030 accreta were identified in our anesthesia database. The diagnosis, surgical procedure, amount of @entity190 and anesthetic management were reviewed. RESULTS: Eight cases of @entity5030 accreta were identified. Four of the eight cases underwent stepwise treatment, and in one of the four cases, @entity432 ( @entity432 ) was performed. The amount of @entity190 in the four cases ranged from 840 to 1,150 ml. The remaining four cases underwent cesarean hysterectomy. The amount of @entity190 in the four cases ranged from 2,400 to 5,200 ml. Neuraxial anesthesia alone was planned in four cases, but in two of which anesthesia was converted to general anesthesia due to @entity548 . CONCLUSIONS: The present retrospective study showed that stepwise treatment and using @entity432 could be an effective aid for management of plasenta previa accreta. It is necessary to compare the effectiveness of @entity432 with that of common iliac @entity432 in reducing the amount of @entity190 .
